SGLT2 Inhibitors Linked to Cardiorenal Benefits Across CKM Syndrome Stages 2–4
A large analysis of clinical-trial evidence suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors protect the heart and kidneys across multiple ...
Tag: cardiovascular-kidney-metabolic syndrome
Artery Damage Found in Twentysomethings Underscores Need for Early Heart Risk Checks
DALLAS, Aug. 20, 2026 — A study of young adults in the United States has found that nearly eight in ...
New Guideline Links Weight to Health Risks Including Diabetes, Kidney, and Heart Diseases
In a groundbreaking advancement for medicine, the American Heart Association and the American College of Cardiology have jointly released the ...
Urea-Activated Nanocarrier Targets Metabolic and Kidney Health
In the ever-advancing landscape of biomedical research, a groundbreaking study has emerged that could redefine therapeutic strategies for complex metabolic ...
Millions Unaware That Heart Risks Often Originate Outside the Heart
Diabetes and kidney disease have long been recognized as individual health concerns; however, their complex interrelation with cardiovascular health unveils ...
Glucose Disposal Rate Linked to Mortality Risk
In recent years, the intersection of cardiovascular health, kidney function, and metabolic disorders has garnered significant attention in the medical ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!